Human mast cells express two leukotriene C4 synthase isoenzymes and the CysLT1 receptor

Cysteinyl-leukotrienes (cys-LTs) are potent smooth muscle contracting agents, especially in the respiratory tract and microcirculation, and play a key role in inflammatory and allergic diseases. The final step in the biosynthesis of LTC₄, the parent compound of cys-LTs, is catalyzed by a specific GSH transferase termed LTC₄ synthase, which is typically expressed in certain bone marrow-derived cells such as eosinophils and mast cells.Here we report that the human mast cell line HMC-1 as well as human mast cells derived from cord blood (CBMC) express a second enzyme capable of synthesizing leukotriene C₄, i.e., microsomal GSH transferase type 2. Furthermore, these cells abundantly express CysLT₁ receptors that are mostly located at the surface of both types of mast cells, as judged by immunohistochemistry. In addition, stimulation of CBMC with LTC₄ and LTD₄ elicits an immediate and dose-dependent (10^?7–10^?11 M) mobilization of intracellular Ca²⁺, which can be blocked with specific CysLT₁ receptor antagonists. Taken together, our data suggest that human mast cells are equipped with two enzymes that can catalyze the committed step in the biosynthesis of cys-LTs. Moreover, the expression of the cognate receptor CysLT₁ suggests that these lipid mediators may be involved in autocrine signaling pathways regulating mast cell functions.